Sartorius Stedim Biotech S.A.
$189.63+1.19%(+$2.23)
TickerSpark Score
62/100
57
Valuation
70
Profitability
80
Growth
72
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SDMHF research report →
52-Week Range13% of range
Low $178.30
Current $189.63
High $264.30
Companywww.sartorius.com
Sartorius Stedim Biotech S. A. produces and sells instruments and consumables for the biopharmaceutical industry worldwide.
- CEO
- Rene Faber
- IPO
- 2009
- Employees
- 9,961
- HQ
- Aubagne, FR
Price Chart
-14.19% · this period
Valuation
- Market Cap
- $18.45B
- P/E
- 59.44
- P/S
- 5.34
- P/B
- 3.88
- EV/EBITDA
- 21.40
- Div Yield
- 0.42%
Profitability
- Gross Margin
- 44.71%
- Op Margin
- 18.47%
- Net Margin
- 8.98%
- ROE
- 6.60%
- ROIC
- 5.47%
Growth & Income
- Revenue
- $2.97B · 6.70%
- Net Income
- $265.50M · 51.63%
- EPS
- $2.73 · 50.83%
- Op Income
- $548.79M
- FCF YoY
- -69.42%
Performance & Tape
- 52W High
- $264.30
- 52W Low
- $178.30
- 50D MA
- $194.21
- 200D MA
- $216.27
- Beta
- 1.09
- Avg Volume
- 2.27K
Get TickerSpark's AI analysis on SDMHF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our SDMHF Coverage
We haven't published any research on SDMHF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SDMHF Report →